IL141165A0 - New imidazopyridine compounds for the inhibition of acid secretion, pharmaceutical compositions thereof and process for preparing the same - Google Patents

New imidazopyridine compounds for the inhibition of acid secretion, pharmaceutical compositions thereof and process for preparing the same

Info

Publication number
IL141165A0
IL141165A0 IL14116599A IL14116599A IL141165A0 IL 141165 A0 IL141165 A0 IL 141165A0 IL 14116599 A IL14116599 A IL 14116599A IL 14116599 A IL14116599 A IL 14116599A IL 141165 A0 IL141165 A0 IL 141165A0
Authority
IL
Israel
Prior art keywords
inhibition
preparing
pharmaceutical compositions
same
acid secretion
Prior art date
Application number
IL14116599A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL141165A0 publication Critical patent/IL141165A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14116599A 1998-08-21 1999-08-18 New imidazopyridine compounds for the inhibition of acid secretion, pharmaceutical compositions thereof and process for preparing the same IL141165A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802793A SE9802793D0 (sv) 1998-08-21 1998-08-21 New compounds
PCT/SE1999/001401 WO2000010999A2 (fr) 1998-08-21 1999-08-18 Nouveaux composes

Publications (1)

Publication Number Publication Date
IL141165A0 true IL141165A0 (en) 2002-11-10

Family

ID=20412306

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14116599A IL141165A0 (en) 1998-08-21 1999-08-18 New imidazopyridine compounds for the inhibition of acid secretion, pharmaceutical compositions thereof and process for preparing the same

Country Status (22)

Country Link
US (1) US6613775B1 (fr)
EP (1) EP1105390B1 (fr)
JP (1) JP2002523414A (fr)
KR (1) KR20010072797A (fr)
CN (1) CN1161355C (fr)
AR (1) AR020225A1 (fr)
AT (1) ATE242242T1 (fr)
AU (1) AU770511B2 (fr)
BR (1) BR9913102A (fr)
CA (1) CA2339372A1 (fr)
DE (1) DE69908608T2 (fr)
DK (1) DK1105390T3 (fr)
ES (1) ES2201769T3 (fr)
HK (1) HK1036274A1 (fr)
IL (1) IL141165A0 (fr)
MY (1) MY121387A (fr)
NO (1) NO20010861L (fr)
NZ (1) NZ509744A (fr)
PT (1) PT1105390E (fr)
SE (1) SE9802793D0 (fr)
WO (1) WO2000010999A2 (fr)
ZA (1) ZA200100911B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
CA2503290C (fr) 2003-03-10 2012-12-04 Altana Pharma Ag Nouveau procede de preparation de roflumilast
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1670795A1 (fr) * 2003-09-18 2006-06-21 ALTANA Pharma AG Imidazo¬4,5-c|pyridines substituees au position 6
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2－a]吡啶衍生物
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2575345A1 (fr) * 2004-08-02 2006-02-09 Altana Pharma Ag 1h-pyrrolo[3,2-b]pyridines 5-substituees
KR101068355B1 (ko) * 2005-03-09 2011-09-28 주식회사유한양행 신규의 이미다조[1,2-ａ]피리딘 유도체 및 그의 제조방법
CA2601250C (fr) 2005-03-16 2014-10-28 Nycomed Gmbh Forme posologique a gout masque
TW200700064A (en) * 2005-03-24 2007-01-01 Glaxo Group Ltd Novel compounds
US8884034B2 (en) 2009-07-08 2014-11-11 Dermira (Canada), Inc. TOFA analogs useful in treating dermatological disorders or conditions
EP2452680B1 (fr) 2009-07-09 2019-12-18 RaQualia Pharma Inc. Antagoniste de la pompe à acide destiné au traitement de maladies associées à un transit gastro-intestinal anormal

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers

Also Published As

Publication number Publication date
ES2201769T3 (es) 2004-03-16
NO20010861D0 (no) 2001-02-20
PT1105390E (pt) 2003-10-31
WO2000010999A2 (fr) 2000-03-02
CN1161355C (zh) 2004-08-11
WO2000010999A3 (fr) 2000-06-02
CN1323308A (zh) 2001-11-21
MY121387A (en) 2006-01-28
NO20010861L (no) 2001-04-10
AU5767899A (en) 2000-03-14
AU770511B2 (en) 2004-02-26
DK1105390T3 (da) 2003-09-22
BR9913102A (pt) 2001-05-08
NZ509744A (en) 2003-05-30
JP2002523414A (ja) 2002-07-30
CA2339372A1 (fr) 2000-03-02
DE69908608T2 (de) 2004-04-29
HK1036274A1 (en) 2001-12-28
AR020225A1 (es) 2002-05-02
EP1105390B1 (fr) 2003-06-04
DE69908608D1 (de) 2003-07-10
EP1105390A2 (fr) 2001-06-13
ZA200100911B (en) 2002-05-02
KR20010072797A (ko) 2001-07-31
ATE242242T1 (de) 2003-06-15
US6613775B1 (en) 2003-09-02
SE9802793D0 (sv) 1998-08-21

Similar Documents

Publication Publication Date Title
HK1030216A1 (en) Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
HUP0201376A2 (en) Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds
HUP0203142A3 (en) Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use
HUP0103376A3 (en) New 3-aryl-2-hydroxypropionic acid derivative, pharmaceutical compositions containing it, process for their preparation and their use
HUP0204226A3 (en) Quinazoline derivatives, pharmaceutical compositions containing them, their use and process for the preparation of the compounds
HUP0004120A3 (en) Use of cgmp-pde5 inhibitors for the preparation of pharmaceutical compositions treating neuropathy
HUP0202100A3 (en) Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same
HUP0203183A3 (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use
HUP0102556A3 (en) Benzenesulfonamide-derivatives and their use as medicaments and process for the preparation of the compounds
HUP0102425A3 (en) Imidazo pyridine derivatives which inhibit gastric acid secretion, process for producing them and pharmaceutical compositions containing them
HUP0104964A3 (en) Quinazoline derivatives as angiogenesis inhibitors, process for their preparation and medicaments containing the compounds
HUP0203122A3 (en) Fab i inhibitors, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203136A3 (en) Piperazine compounds, process for their preparation, pharmaceutical compositions containing them and their use
HUP0200881A2 (en) Renin inhibitors, process for preparation of the compounds, pharmaceutical compositions containing them and their use
HUP0300592A3 (en) Process for the preparation of 2-halobenzoic acid derivatives
IL141165A0 (en) New imidazopyridine compounds for the inhibition of acid secretion, pharmaceutical compositions thereof and process for preparing the same
IL146104A0 (en) Substituted bicyclic heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing the same
HUP0203471A3 (en) Antithrombotic compound, process for their preparation, pharmaceutical compositions containing them and their use
EG22344A (en) Process for preparing of novel pharmaceutical composition
IL131644A0 (en) Process for the preparation of nicotinic acid
HUP0103788A3 (en) Processes for the preparation of 5-hydroxy-3-oxopentanoic acid derivatives
HUP0202988A3 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one derivatives and their use as lipase inhibitors, process for their preparation and pharmaceutical compositions containing them
PL352280A1 (en) Derivatives of naphthyridine, method of making same, use of same and pharmaceutical compositions containing these derivatives
GB2363605B (en) Process for the preparation of alpha-aminoketone derivatives
AU7958000A (en) Process for the preparation of oxyiminoalkanoic acid derivatives